IVI announces five-year, core support pact with Sweden

IVI announces five-year, core support pact with Sweden

[Undated] SEOUL, KOREA – The International Vaccine Institute announced today that it has a five-year agreement on core support with the Swedish International Development Cooperation Agency (Sida). Sida has agreed to support IVI’s core activities to help fulfill the Institute’s mission to discover, develop, and deliver safe, effective, and affordable vaccines for the world’s developing nations. The Swedish contribution totals 34.5 million Swedish Krona (approximately $5 million USD) and is effective from 2015 to 2019.

“We are extremely grateful to Sida and the Swedish government for their commitment to IVI,” said Mr. John Morahan, IVI’s Acting Director General and Chief Financial Officer, “With previous Swedish support, IVI led the initiative to accelerate the development and introduction of the world’s first low-cost oral cholera vaccine. This vaccine was prequalified by the World Health Organization and is now being used to fight cholera around the world by agencies such as UNICEF.”…